Objectives To determine if the presence of microorganisms in follicular fluid of women undergoing in vitro fertilization-embryo transfer (IVF-ET) adversely affects the outcome of the treatment cycles. Methods Follicular fluid was collected from 86 women enrolled for IVF-ET at the National Hospital, Abuja from June 1, 2018 to December 1, 2018. Microscopy imaging and cultures were performed to identify bacteria and fungi in the follicular fluid and the vagina. Women with follicular fluid microorganisms were the test group while the controls were those without follicular fluid microorganisms. Fertilization and pregnancy rates were subsequently determined and their association with the presence of follicular fluid microorganisms was assessed using univariable and multivariable logistic regression modelling. Results The mean age and mean Body Mass Index (BMI) of the participants were 35(± 3.5) years and 28(± 4.9) kg/m2 respectively. Bacteria and fungi were isolated in 17% of the follicular fluid samples collected (n = 15/86). Most common isolates were Streptococcus spp. (n = 4/15), Staphylococcus aureus (n = 7/15), Enterococcus spp. (n = 4/15), Lactobacillus species (n = 2/15) and Candida albicans (n = 2/15). There was no statistically significant difference in the fertilization rates (adjusted odds ratio [AdjOR] 0.55, 95% confidence interval [CI] 0.04–7.34; P = 0.10) and pregnancy rates (AdjOR 4.02, 95% CI 0.56–28.92; P = 0.19) between the group of women with positive follicular fluid bacterial /fungal colonization as compared against those with negative follicular fluid colonization. Conclusion Isolation of microorganisms from follicular fluid did not adversely affect fertilization and pregnancy rates following IVF-ET treatment cycles at the fertility centre of National Hospital, Abuja.

Background: Hysterosalpingography is dreaded by women due to pain. Pain intensity varies with different stages of the procedure and the search for an effective analgesia continues. Objective: To compare the effectiveness of suppository diclofenac (100mg), cervical lidocaine 25mg -prilocaine 25mg cream (5% EMLA) and placebo in pain relief for hysterosalpingography. Methodology: This was a prospective, randomized, double-blinded, placebo-controlled study conducted at National Hospital Abuja, Nigeria, between November 2018 and March 2019. Participants were allocated to three groups (A, B, C). Group A received suppository diclofenac 100mg plus placebo cream, group B got EMLA cream plus placebo suppository while group C received placebo suppository and cream. Pain levels were assessed using Visual Analogue Scale (VAS) at baseline, during 4 different stages of the procedure, at 30 minutes and 24 hours after the procedure. Patients' satisfaction and side effects were also assessed. Data were analyzed using SPSS version 22 (SPSS Inc., Chicago, IL, USA). P value < 0.05 at 95% confidence interval was regarded as statistically significant. Results: The most painful step of the procedure was during uterine distension with contrast medium with mean VAS score of 6.33±1.539, 5.37±1.377, 7.03±1.245 in group A, B and C, respectively (p-value <0.05). Mean pain scores during 4 steps of the procedure were found to be significantly lower in EMLA group. Intervention groups were also more satisfied after the procedure. Conclusion: EMLA 5% cream is a more effective analgesic for HSG compared to both diclofenac and placebo. Keywords: Analgesia; EMLA; diclofenac; hysterosalpingography; visual analogue scale.